Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.65 - $3.92 $308,865 - $456,887
-116,553 Reduced 68.73%
53,025 $164,000
Q1 2024

May 15, 2024

SELL
$2.59 - $4.65 $1.92 Million - $3.45 Million
-741,560 Reduced 81.39%
169,578 $591,000
Q4 2023

Feb 14, 2024

SELL
$1.54 - $3.37 $1.06 Million - $2.32 Million
-689,746 Reduced 43.09%
911,138 $2.78 Million
Q3 2023

Nov 14, 2023

SELL
$1.5 - $3.75 $413,262 - $1.03 Million
-275,508 Reduced 14.68%
1,600,884 $3.03 Million
Q2 2023

Aug 14, 2023

BUY
$2.21 - $4.43 $1.24 Million - $2.48 Million
559,429 Added 42.48%
1,876,392 $5.25 Million
Q1 2023

May 15, 2023

SELL
$3.81 - $6.76 $144,608 - $256,575
-37,955 Reduced 2.8%
1,316,963 $5.45 Million
Q4 2022

Feb 14, 2023

BUY
$4.26 - $6.84 $3.53 Million - $5.67 Million
829,584 Added 157.92%
1,354,918 $6.31 Million
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $486,272 - $1.03 Million
80,243 Added 18.03%
525,334 $3.18 Million
Q2 2022

Aug 15, 2022

BUY
$8.35 - $21.89 $1.27 Million - $3.33 Million
152,246 Added 51.99%
445,091 $4.66 Million
Q1 2022

May 16, 2022

BUY
$16.97 - $31.93 $3.46 Million - $6.5 Million
203,668 Added 228.39%
292,845 $6.04 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $41.78 $1.98 Million - $3.23 Million
-77,247 Reduced 46.42%
89,177 $2.79 Million
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $138,729 - $197,609
7,060 Added 4.43%
166,424 $3.87 Million
Q2 2021

Aug 16, 2021

BUY
$17.48 - $25.46 $2.04 Million - $2.97 Million
116,615 Added 272.79%
159,364 $3.61 Million
Q1 2021

May 17, 2021

BUY
$18.08 - $28.8 $772,901 - $1.23 Million
42,749 New
42,749 $979,000
Q2 2019

Aug 14, 2019

SELL
$17.0 - $21.88 $897,294 - $1.15 Million
-52,782 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$15.53 - $22.15 $819,704 - $1.17 Million
52,782 New
52,782 $1.08 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.